Sign In
Buy EHC
$112.50
+0.290 (+0.258%)
At Close: Jul 20, 2026
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 11'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envestnet Asset Management Inc. Reduces Holdings in Encompass Health Corporation $EHC
04:22am, Wednesday, 11'th Feb 2026
Envestnet Asset Management Inc. reduced its position in shares of Encompass Health Corporation (NYSE: EHC) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing
Encompass Health: Structural Advantages In A Fragmented Market
12:58pm, Tuesday, 10'th Feb 2026
Encompass Health stands as the leading U.S. inpatient rehabilitation provider, demonstrating superior clinical quality, capital efficiency, and sustainable double-digit EBITDA growth. EHC benefits fro
Here's Why Encompass Health (EHC) is a Strong Growth Stock
10:45am, Tuesday, 10'th Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Q4 Earnings Beat but Discharges Lag
03:10pm, Monday, 09'th Feb 2026
EHC tops Q4 EPS and revenue estimates as revenue per discharge rises, lifting profits, though higher salaries and benefits weigh on results.
Encompass Health Corporation $EHC Shares Sold by Alps Advisors Inc.
03:08am, Monday, 09'th Feb 2026
Alps Advisors Inc. lessened its stake in shares of Encompass Health Corporation (NYSE: EHC) by 18.0% during the third quarter, according to the company in its most recent disclosure with the Securitie
Encompass Health Q4 Earnings Call Highlights
04:16am, Sunday, 08'th Feb 2026
Encompass Health (NYSE: EHC) reported what executives described as a "very strong" fourth quarter, capping a "stellar" 2025 marked by double-digit revenue growth, expanding EBITDA, and continued reduc
Encompass Health Corporation (EHC) Q4 2025 Earnings Call Transcript
05:34pm, Friday, 06'th Feb 2026
Encompass Health Corporation (EHC) Q4 2025 Earnings Call Transcript
Encompass Health (EHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:30pm, Thursday, 05'th Feb 2026
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Encompass Health (EHC) Q4 Earnings and Revenues Top Estimates
06:50pm, Thursday, 05'th Feb 2026
Encompass Health (EHC) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.17 per share a year ago.
Encompass Health reports results for fourth quarter 2025 and issues 2026 guidance
04:20pm, Thursday, 05'th Feb 2026
BIRMINGHAM, Ala., Feb. 5, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its r
Encompass Health appoints Cain Hayes to its board of directors
08:00am, Monday, 02'nd Feb 2026
BIRMINGHAM, Ala., Feb. 2, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the appointment of Cain A.
Encompass Health Corporation (NYSE:EHC) Short Interest Up 19.7% in December
04:53am, Wednesday, 21'st Jan 2026
Encompass Health Corporation (NYSE: EHC - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totaling 3,479,262 s
SG Americas Securities LLC Buys 6,508 Shares of Encompass Health Corporation $EHC
06:21am, Tuesday, 20'th Jan 2026
SG Americas Securities LLC grew its stake in Encompass Health Corporation (NYSE: EHC) by 643.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange C
Encompass Health Corporation (NYSE:EHC) Receives Consensus Rating of “Buy” from Analysts
02:14am, Saturday, 10'th Jan 2026
Shares of Encompass Health Corporation (NYSE: EHC - Get Free Report) have received an average recommendation of "Buy" from the eleven analysts that are presently covering the stock, MarketBeat Ratings
